Skip to main content

Table 1 Association between NB patients’ clinicopathological factors and miR-149 expression

From: miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma

Clinicopathologic features

N (%)

Relative miR-149 level

P value

High (%)

Low (%)

Total cases

42 (100.0)

15 (35.7)

27 (64.3)

 

Age (years)

   

0.3526

 ≥ 2.5

24 (57.1)

10 (41.7)

14 (58.3)

 

 < 2.5

18 (42.9)

5 (27.8)

13 (72.2)

 

Gender

   

0.3939

 Male

26 (61.9)

8 (30.8)

18 (69.2)

 

 Female

16 (38.1)

7 (43.8)

9 (56.2)

 

INSS stage

   

0.0376

 I–II

19 (45.2)

10 (52.6)

9 (47.4)

 

 III–IV

23 (54.8)

5 (21.7)

18 (78.3)

 

Lymph node metastasis

   

0.0241

 No

27 (64.3)

13 (48.1)

14 (51.9)

 

 Yes

15 (35.7)

2 (13.3)

13 (86.7)

 
  1. NB neuroblastoma, INSS International Neuroblastoma Staging System